Terms: = Bone cancer AND CREB3L1, 90993, Q96BA8, OASIS, ENSG00000157613
15 results:
1. Sclerosing Epithelioid Fibrosarcoma.
Warmke LM; Yu W; Meis JM
Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
[TBL] [Abstract] [Full Text] [Related]
2. The Regulatory Network of creb3l1 and Its Roles in Physiological and Pathological Conditions.
Zhao Y; Yu Z; Song Y; Fan L; Lei T; He Y; Hu S
Int J Med Sci; 2024; 21(1):123-136. PubMed ID: 38164349
[TBL] [Abstract] [Full Text] [Related]
3. Diagnosis- and Prognosis-Related Gene Alterations in
Morishita S; Komatsu N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
[No Abstract] [Full Text] [Related]
4. Sclerosing epithelioid fibrosarcoma of bone with hybrid features: clinicopathologic, radiologic, and molecular analysis of three cases.
Suster DI; Gross JM; Fayad L; Wenokor C; Goldsmith JD; Ward A; Early C; Lazano-Calderon S; Klein MJ
Skeletal Radiol; 2024 Feb; 53(2):387-393. PubMed ID: 37524934
[TBL] [Abstract] [Full Text] [Related]
5. Metastatic cancer along ancient Silk Road: A possible case from Xinjiang (China).
He L; Gibbon VE; Xiao X; Wang B; Li H
Int J Paleopathol; 2022 Jun; 37():23-29. PubMed ID: 35366493
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical impact of gene mutations on myeloproliferative neoplasms in Japan].
Morishita S
Rinsho Ketsueki; 2021; 62(8):1060-1069. PubMed ID: 34497192
[TBL] [Abstract] [Full Text] [Related]
7. creb3l1 overexpression as a potential diagnostic marker of Philadelphia chromosome-negative myeloproliferative neoplasms.
Morishita S; Yasuda H; Yamawaki S; Kawaji H; Itoh M; Edahiro Y; Imai M; Kogo Y; Tsuneda S; Ohsaka A; Hayashizaki Y; Ito M; Araki M; Komatsu N
Cancer Sci; 2021 Feb; 112(2):884-892. PubMed ID: 33280191
[TBL] [Abstract] [Full Text] [Related]
8. Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.
Kosemehmetoglu K; Ardic F; Kilpatrick SE; Aydingoz U; Sumathi VP; Michal M
Virchows Arch; 2021 Apr; 478(4):767-777. PubMed ID: 33084978
[TBL] [Abstract] [Full Text] [Related]
9. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
Warmke LM; Meis JM
Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
[TBL] [Abstract] [Full Text] [Related]
10. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract] [Full Text] [Related]
11. Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature.
Tsuda Y; Dickson BC; Dry SM; Federman N; Suurmeijer AJH; Swanson D; Sung YS; Zhang L; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Apr; 59(4):217-224. PubMed ID: 31675134
[TBL] [Abstract] [Full Text] [Related]
12. Sclerosing Epithelioid Fibrosarcoma of the Jaw: Late Recurrence from a Low Grade Fibromyxoid Sarcoma.
Laliberte C; Leong IT; Holmes H; Monteiro EA; O'Sullivan B; Dickson BC
Head Neck Pathol; 2018 Dec; 12(4):619-622. PubMed ID: 29274042
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic Sclerosing Epithelioid Fibrosarcoma in bone Marrow.
Asakra R; Zaidi S; Thway K
Int J Surg Pathol; 2017 Dec; 25(8):702-704. PubMed ID: 28697683
[TBL] [Abstract] [Full Text] [Related]
14. oasis/creb3l1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
[TBL] [Abstract] [Full Text] [Related]
15. EWSR1-creb3l1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma.
Lau PP; Lui PC; Lau GT; Yau DT; Cheung ET; Chan JK
Am J Surg Pathol; 2013 May; 37(5):734-8. PubMed ID: 23588368
[TBL] [Abstract] [Full Text] [Related]
